← Clinical Evidence

SRC-8003da04a2bd Macleod AD 2018

Evidence source and scope

Macleod AD, Dalen I, Tysnes OB, Larsen JP, Counsell CE. Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease. Movement Disorders. 2018;33:108–116. Published online 2017. Original article

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1002/mds.27177

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Macleod AD, Dalen I, Tysnes OB, Larsen JP, Counsell CE. Development and validation of prognostic survival models in newly diagnosed Parkinson’s disease. Movement Disorders. 2018;33:108–116. Published online 2017. Original article

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — transfer

PINE n=198 and ParkWest n=192 mortality cohorts; eight-item axial score includes chair rise. Per five points, dependency HR 1.74 (1.28–2.35), mortality HR 1.33 (1.08–1.66); external overprediction required recalibration. Dependency excludes 22/30 already dependent, leaving n=176/162.

Limitations: Only the enumerated transfer-relevant components were adjudicated. Source availability does not imply every statement, supplement, figure or raw datum was checked.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide